1. Cancer, psychologic factors, and behavior: A complex and controversial relationship

   • Maurie Markman

   Editor’s Commentary Pages: 2 - 3

2. Literature alert

   Abstract Pages: 5 - 6

3. Web alert

   News Pages: 7 - 7

4. Novel antineoplastic agents

   • Ronald M. Bukowski

   OriginalPaper Pages: 9 - 10

5. Angiogenesis inhibitors

   • Thelma R. Tennant
   • Carrie W. Rinker-Schaeffer
   • Walter M. Stadler

   OriginalPaper Pages: 11 - 16

6. Prodrug/drug sensitivity gene therapy: Current status

   • W. Roy Smythe

   OriginalPaper Pages: 17 - 22

7. Antisense cancer therapy: The state of the science

   • David M. Kushner
   • Robert H. Silverman

   OriginalPaper Pages: 23 - 30

8. Novel oral chemotherapy agents

   • Melanie E Royce
   • Paulo M. Hoff
   • Richard Pazdur

   OriginalPaper Pages: 31 - 37

9. Melanoma peptide vaccines: From preclinical background to clinical trials

   • Jeffrey Weber

   OriginalPaper Pages: 38 - 47

10. Postoperative radiotherapy in resected non-small-cell lung cancer: Every creek has two banks

    • David H. Johnson
    • Andrew Turrisi

    Clinical Trials Review Pages: 51 - 53

11. Induction chemotherapy or chemoradiotherapy before surgery for non-small-cell lung cancer

    • Kathy S. Albain

    OriginalPaper Pages: 54 - 63

12. Gene therapy in lung cancer

    • Stephen G. Swisher
    • Jack A. Roth

    OriginalPaper Pages: 64 - 70

13. Hyperfractionated radiotherapy for lung cancer

    • Eric L. Gressen
    • Walter J. Curran Jr

    OriginalPaper Pages: 71 - 75

14. The role of new agents in advanced non—small–cell lung carcinoma

    • Corey J. Langer

    OriginalPaper Pages: 76 - 89

15. Management of elderly patients with lung cancer

    • Malcolm R. Ranson
    • Shane White
    • Nicholas Thatcher

    OriginalPaper Pages: 90 - 95

16. Second–line chemotherapy for non—small–cell lung cancer

    • Frank V. Fossella

    OriginalPaper Pages: 96 - 101